what are glp-1 receptor agonists as Treatments for Type 2 Diabetes GLP-1 receptor agonists show promise

Huge congratulations to the authors!

Scott, and nationwide shipping.

Grocery list included.

Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMSs Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for these drugs.

Here's a practical breakdown of how coverage works, what prior authorization involves, and what your options are if you're paying out of pocket.